Cargando…
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions
Estrogen receptor-α (ER) drives tumor development in ER-positive (ER+) breast cancer. The transcription factor GATA3 has been closely linked to ER function, but its precise role in this setting remains unclear. Quantitative proteomics was used to assess changes to the ER complex in response to GATA3...
Autores principales: | Broome, Rebecca, Chernukhin, Igor, Jamieson, Stacey, Kishore, Kamal, Papachristou, Evangelia K., Mao, Shi-Qing, Tejedo, Carmen Gonzalez, Mahtey, Areeb, Theodorou, Vasiliki, Groen, Arnoud J., D’Santos, Clive, Balasubramanian, Shankar, Farcas, Anca Madalina, Siersbæk, Rasmus, Carroll, Jason S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921846/ https://www.ncbi.nlm.nih.gov/pubmed/33626359 http://dx.doi.org/10.1016/j.celrep.2021.108776 |
Ejemplares similares
-
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
por: Lio, Chan-Wang J., et al.
Publicado: (2019) -
Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
por: Jiang, Jinhua, et al.
Publicado: (2021) -
Exploring role of 5hmC as potential marker of chemoresistance
por: Kharat, Suhas S., et al.
Publicado: (2020) -
5mC and 5hmC dynamics during PGC reprogramming and role of Tet1 in female meiosis
por: Yamaguchi, Shinpei, et al.
Publicado: (2013) -
IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC
por: Xu, Qiang, et al.
Publicado: (2016)